The 2026 version of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report has been published. Key ...
The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.
The procedure is called bronchoscopic lung volume reduction. It involves inserting small valves into the air tubes of the ...
3d
Long-term exposure to black carbon linked to risk for asthma, chronic obstructive pulmonary disease
Long-term exposure to black carbon (BC) is associated with an increased risk for developing asthma and chronic obstructive pulmonary disease (COPD), according to a study recently published in ...
Glenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment ...
Capital Market on MSN
Glenmark gains after launching first-ever nebulized triple therapy for COPD
The therapies combine three proven medicines-Glycopyrronium, Formoterol, and Budesonide-to reduce airway obstruction, control ...
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback